Immunological tolerance and enhancement: a common mechanism.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 5106887)

Published in Transplant Proc on March 01, 1971

Authors

R H Levey

Articles by these authors

Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A (1980) 11.23

Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1966) 7.56

Further experiments on the action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1967) 2.31

Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96

Acquisition of immune competence by a subset of human cortical thymocytes expressing mature T cell antigens. J Immunol (1982) 1.34

Cellular immunoabsorbents in transplantation immunity. Specific in vitro deletion and recovery of mouse lymphoid cells sensitized against allogeneic tumors. J Exp Med (1972) 1.27

T-cell migration into allografts. J Exp Med (1975) 1.12

Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus. Lancet (1970) 1.08

Increased tumour induction by adenovirus type 12 in thymectomized mice and mice treated with anti-lymphocyte serum. Nature (1967) 1.05

Bone-marrow transplantation in severe combined immunodeficiency syndrome. Lancet (1971) 1.05

Heterochromia iridis and Horner's syndrome due to paravertebral neurilemmoma. J Surg Oncol (1983) 1.04

The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer (1986) 1.00

Influences of antilymphocyte serum on cell-mediated and antibody-mediated responses. Fed Proc (1970) 0.99

Studies on the isolation of lymphocytes active in cell-mediated immiune responses. II. Identification and recovery of an immunocompetent subpopulation of mouse thymocytes. Cell Immunol (1972) 0.96

Growth acceleration following renal transplantation in children less than 7 years of age. Pediatrics (1981) 0.90

The isoporous substructure of the human glomerular slit diaphragm. Kidney Int (1975) 0.88

Mortality of chronic hemodialysis and renal transplantation in pediatric end-stage renal disease. Pediatrics (1981) 0.86

Tolerance of rat skin grafts in adult mice. Proc Natl Acad Sci U S A (1969) 0.86

Antihelper T cell autoantibody in acquired agammaglobulinemia. J Clin Invest (1981) 0.86

Studies of thymic function. Wistar Inst Symp Monogr (1964) 0.84

Warts in a pediatric renal transplant population. Dermatologica (1977) 0.84

Demonstration of thymic function in vitro. Transplant Proc (1971) 0.82

Treatment of chronic renal allograft rejection with cyclosporine and prednisone. Transplantation (1988) 0.82

Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man. Transplant Proc (1977) 0.81

Studies on the isolation of lymphocytes active in cell-mediated immune responses. I. Demonstration of an active population of thymus-derived cells in mouse bone marrow. Cell Immunol (1972) 0.81

Aplastic anemia: lack of inhibitory effect of bone marrow lymphocytes on in vitro granulopoiesis. Blood (1980) 0.80

Unique surgical and immunologic features of renal transplantation in children. J Pediatr Surg (1978) 0.80

Post-transplant hypertension in the absence of rejection or recurrent disease. Clin Nephrol (1981) 0.80

Outcome of renal transplantation in children less than two years of age. Kidney Int (1992) 0.79

Surgical techniques for vascular access for chemotherapy in infants and children. J Pediatr Surg (1978) 0.79

Mechanism of action of antilymphoid antisera. Surg Forum (1966) 0.79

Effect of antilymphocyte serum on the thymus. Transplant Proc (1969) 0.78

Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. Blood (1978) 0.78

Cholelithiasis and Wilson disease. J Pediatr (1978) 0.78

Progressive tubulointerstitial renal disease in infancy with associated hepatic abnormalities. Am J Med (1986) 0.78

Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia. Transplantation (1985) 0.77

Lymphocytic Choriomeningitis Infection in Neonataily Thymectomized Mice Bearing Diffusion Chambers Containing Thymus. Science (1963) 0.76

Mortality of chronic hemodialysis comparable to that of renal transplantation in pediatric end-stage renal disease. Proc Clin Dial Transplant Forum (1979) 0.75

Glycerin toxicity in an infant following enteric administration. J Pediatr Surg (1978) 0.75

Correlation of early acute rejection episodes with long-term renal transplant outcome. Transplantation (1982) 0.75

A comparison of the models of immunological tolerance and enhancement. Transplant Proc (1972) 0.75

Lymphocyte ecology and immunologic tolerance. Transplant Proc (1973) 0.75

Maintenance of vascular access patency in pediatrics. Pediatr Radiol (1986) 0.75

Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation. J Immunol (1982) 0.75

Induction of tolerance to skin homografts with a methylhydrazine derivative. Synergism with antilymphocytic serum and morphologic responses of the lymphoid system. Agents Actions (1970) 0.75

The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model. Transplant Proc (1972) 0.75

The surgical management of fungal pulmonary infections in children with acute myelogenous leukemia. J Pediatr Surg (1985) 0.75

The induction of long-term immunological tolerance. J Pediatr Surg (1971) 0.75

Successful bone marrow transplantation in sensitized recipients. Transplant Proc (1979) 0.75

Lymphocyte environment and the durability of transplantation tolerance. Transplant Proc (1972) 0.75

Renal growth after transplantation: infant kidney received by adolescent. Clin Nephrol (1981) 0.75

Workshop on immunosuppression by biologic methods. Transplant Proc (1979) 0.75

Studies on the isolation of lymphocytes active in cell-mediated immune responses. 3. The pattern of recovery of immuno-competence by various lymphoid cell populations following cessation of chronic administration of antilymphocyte serum. Cell Immunol (1972) 0.75